Patent · US Expired

Method of treating benign prostatic hypertrophy

US4330559A · kind A · utility

24Cited by

1References

8Claims

0Family size

Assignee

Merrell-Toraude et Cie · FR

Inventors

Philippe Bey · Cincinnati, US
Michel Jung · Illkirch-Graffenstaden, FR

Key dates

Filing date	Feb 3, 1981
Grant date	May 18, 1982
Priority date	—
Expiry date	Feb 3, 2001

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is described a method for treating benign prostatic hypertrophy comprising the administration of 2,5-di-amino-2-(mono-,di-, or trifluoromethyl)pentanoic acid or derivative thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.